Dow Today: Pfizer (PFE) Leads The Day Higher, JPMorgan Chase (JPM) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 92 points (+0.6%) at 16,453 as of Monday, Apr 28, 2014, 9:36 a.m. ET. During this time, 26.6 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 415.8 million. The NYSE advances/declines ratio sits at 1,613 issues advancing vs. 1,138 declining with 247 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Pfizer (NYSE: PFE), which is sporting a 92-cent gain (+3%) bringing the stock to $31.66. This single gain is lifting the Dow Jones Industrial Average by 6.96 points or roughly accounting for 7.6% of the Dow's overall gain. Volume for Pfizer currently sits at 6.1 million shares traded vs. an average daily trading volume of 28.7 million shares.

Pfizer has a market cap of $196.35 billion and is part of the health care sector and drugs industry. Shares are up 0.4% year-to-date as of Friday's close. The stock's dividend yield sits at 3.3%.

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Its product portfolio includes medicines and vaccines, as well as various consumer healthcare products. The company has a P/E ratio of 19.4, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

Holding back the Dow today is JPMorgan Chase (NYSE: JPM), which is lagging the broader Dow index with a 45-cent decline (-0.8%) bringing the stock to $55.25. Volume for JPMorgan Chase currently sits at 931,933 shares traded vs. an average daily trading volume of 19.7 million shares.

JPMorgan Chase has a market cap of $212.68 billion and is part of the financial sector and banking industry. Shares are down 4.8% year-to-date as of Friday's close. The stock's dividend yield sits at 2.6%.

JPMorgan Chase & Co., a financial holding company, provides various financial services worldwide. The company operates through four segments: Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset Management. The company has a P/E ratio of 13.3, below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates JPMorgan Chase as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, attractive valuation levels and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists